When
Where
Can the U.S. Biologics Price Competition and Innovation Act Achieve Its Promise? A Decade Review Presented by: Tara Sklar, JD, MPH, Professor of Health Law, University of Arizona, James E. Rogers College of Law
- Become familiar with the Biologics Price Competition and Innovation Act (BPCIA), its intent to increase market competition, and progress to date.
- Learn more about the FDA abbreviated pathway for approval of biosimilars created under BPICA and implementation of the FDA Biosimilars Action Plan.
- Consider proposed recommendations to support the stated promise of BPCIA, which is to lower the price of biologics via increased market competition, by improving transparency with disclosure of biologics manufacturing information. 10 AM EST/7 AM MST https://secure.terrapinn.com/V5/guest/10339/a064G00001LMK0zQAH/0054G000…